265 related articles for article (PubMed ID: 2318423)
1. Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.
Sahlin S; Ahlberg J; Einarsson K; Henriksson R; Danielsson A
Gut; 1990 Jan; 31(1):100-5. PubMed ID: 2318423
[TBL] [Abstract][Full Text] [Related]
2. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
[TBL] [Abstract][Full Text] [Related]
3. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
[TBL] [Abstract][Full Text] [Related]
4. Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.
Hussaini SH; Pereira SP; Murphy GM; Kennedy C; Wass JA; Besser GM; Dowling RH
Gut; 1995 Jan; 36(1):126-32. PubMed ID: 7890216
[TBL] [Abstract][Full Text] [Related]
5. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
Lanzini A; Northfield TC
Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting gall-stone dissolution rate during chenic acid therapy.
Maudgal DP; Kupfer RM; Northfield TC
Gut; 1983 Jan; 24(1):7-10. PubMed ID: 6848433
[TBL] [Abstract][Full Text] [Related]
7. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
Ruppin DC; Murphy GM; Dowling RH
Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
[TBL] [Abstract][Full Text] [Related]
8. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
9. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
11. Chemical and physical properties of gall stones in South Australia: implications for dissolution treatment.
Whiting MJ; Bradley BM; Watts JM
Gut; 1983 Jan; 24(1):11-5. PubMed ID: 6848428
[TBL] [Abstract][Full Text] [Related]
12. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins.
MacPherson BR; Pemsingh RS
Microsc Res Tech; 1997 Oct; 39(1):39-55. PubMed ID: 9329018
[TBL] [Abstract][Full Text] [Related]
13. Gall bladder epithelium and cholesterol gall stones.
Caselli ME; Morsiani E; Aleotti A; Alvisi V
Gut; 1990 Dec; 31(12):1423. PubMed ID: 2088330
[No Abstract] [Full Text] [Related]
14. Duodenal bile examination in identifying potential non-responders to bile salt treatment and its comparison with gall bladder bile examination.
Agarwal DK; Choudhuri G; Saraswat VA; Negi TS; Kapoor VK; Saxena R
Gut; 1994 Jan; 35(1):112-6. PubMed ID: 8307430
[TBL] [Abstract][Full Text] [Related]
15. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
Smallwood RA; Jablonski P; Watts JM
Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.
Rhodes M; Allen A; Dowling RH; Murphy G; Lennard TW
Gut; 1992 Aug; 33(8):1113-7. PubMed ID: 1398238
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium.
Miquel JF; Moreno M; Amigo L; Molina H; Mardones P; Wistuba II; Rigotti A
Gut; 2003 Jul; 52(7):1017-24. PubMed ID: 12801960
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis].
Il'chenko AA; Orlova IuN
Eksp Klin Gastroenterol; 2003; (1):46-50, 182. PubMed ID: 12664784
[TBL] [Abstract][Full Text] [Related]
20. Free fatty acids stimulate mucin hypersecretion by rabbit gall-bladder epithelium in vitro.
Mingrone G; Greco AV; Arcieri Mastromattei E
Clin Sci (Lond); 1990 Feb; 78(2):175-80. PubMed ID: 2155745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
